Beam Therapeutics Inc. (BEAM)

29.32USD -3.81% (-1.16)

Over 1M: +14.9%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

26 28 30
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '23 — Revenue: 17.2M Q4 '23 — Revenue: 316.2M Q1 '24 — Revenue: 7.4M Q2 '24 — Revenue: 11.8M Q3 '24 — Revenue: 14.3M Q4 '24 — Revenue: 30.1M Q1 '25 — Revenue: 7.5M Q2 '25 — Revenue: 8.5M Q3 '25 — Revenue: 9.7M Q4 '25 — Revenue: 114.1M Q1 '26 — Revenue: 31.7M Q2 '26 — Revenue: 490K 0 70M 140M 210M 280M 350M
Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 62 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 52.2%
OE margin -291.1%
Oper. margin -242.3%
ROIC -2021.5%
Accruals 19.7%
EBITDA margin -228.0%
FCF margin -238.9%
OCF margin -230.3%
Profit margin -55.4%
ROA -6.2%
ROCE -29.0%
ROE -8.1%
Gross margin —
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

2.6
EV/Sales 12.7×
EV/OE -4.3×
P/C 2.6×
P/B 2.8×
FCF yield -12.3%
Div. yield —
EV/EBIT —
EV/GP —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO / sales —
RPO growth —
Segment HHI —

2 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

7.8
Current ratio 14.6×
ND/EBITDA 0.53
Cash runway 2.8 yr
Cash / Debt 11.5×
Debt / Eq 0.094×
Debt payback 0.0 yr
Quick ratio 14.6×
F-score 3.9 pts
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

8.5
Sales/sh Y/Y +115.4%
Sales CAGR 4Y +28.1%
Sales Q/Q -94.2%
Shares change +20.2%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.